106 related articles for article (PubMed ID: 12515198)
1. [The study on in vivo erythropoietin gene transfer for treatment of renal anemia in animal model].
Sui B; Han F; Wu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):161-4. PubMed ID: 12515198
[TBL] [Abstract][Full Text] [Related]
2. [The effects of electroporation-mediated erythropoietin (EPO) gene transfer into skeleton muscle on renal anemia].
Lu X; Zhou A; Jin C
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):222-5. PubMed ID: 11798762
[TBL] [Abstract][Full Text] [Related]
3. Control of erythropoietin gene expression and its use in medicine.
Jelkmann W
Methods Enzymol; 2007; 435():179-97. PubMed ID: 17998055
[TBL] [Abstract][Full Text] [Related]
4. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats.
Maruyama H; Ataka K; Gejyo F; Higuchi N; Ito Y; Hirahara H; Imazeki I; Hirata M; Ichikawa F; Neichi T; Kikuchi H; Sugawa M; Miyazaki J
Gene Ther; 2001 Mar; 8(6):461-8. PubMed ID: 11313825
[TBL] [Abstract][Full Text] [Related]
5. Skin-targeted gene transfer using in vivo electroporation.
Maruyama H; Ataka K; Higuchi N; Sakamoto F; Gejyo F; Miyazaki J
Gene Ther; 2001 Dec; 8(23):1808-12. PubMed ID: 11803401
[TBL] [Abstract][Full Text] [Related]
6. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
[TBL] [Abstract][Full Text] [Related]
7. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene.
Oh TK; Quan GH; Kim HY; Park F; Kim ST
Am J Nephrol; 2006; 26(4):326-34. PubMed ID: 16825758
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.
Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F
Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775
[TBL] [Abstract][Full Text] [Related]
9. The potential of erythropoietin and related strategies to stimulate erythropoiesis.
Eckardt KU
Curr Opin Investig Drugs; 2001 Aug; 2(8):1081-5. PubMed ID: 11892917
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
[TBL] [Abstract][Full Text] [Related]
11. [What are the aims and targets of renal anemia therapy?].
Eckardt KU
Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
[No Abstract] [Full Text] [Related]
12. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
[TBL] [Abstract][Full Text] [Related]
13. Role of erythropoietin in anemia after heart transplantation.
Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
[TBL] [Abstract][Full Text] [Related]
14. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin gene transfer into rat testes by in vivo electropo-ration may reduce the risk of germ cell loss caused by cryptorchidism.
Dobashi M; Goda K; Maruyama H; Fujisawa M
Asian J Androl; 2005 Dec; 7(4):369-73. PubMed ID: 16281083
[TBL] [Abstract][Full Text] [Related]
16. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates.
Fattori E; Cappelletti M; Zampaglione I; Mennuni C; Calvaruso F; Arcuri M; Rizzuto G; Costa P; Perretta G; Ciliberto G; La Monica N
J Gene Med; 2005 Feb; 7(2):228-36. PubMed ID: 15515133
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO].
Dyjas R; Wiecek A; Kokot F
Przegl Lek; 1996; 53(6):486-90. PubMed ID: 8927751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene.
Osada S; Ebihara I; Setoguchi Y; Takahashi H; Tomino Y; Koide H
Kidney Int; 1999 Apr; 55(4):1234-40. PubMed ID: 10200985
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
Eliopoulos N; Gagnon RF; Francois M; Galipeau J
J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
